Objective: This study aimed to predict the effect of SNPs CYP2C9 s on the metabolic activity of S-warfarin in the body. Methods: Molecular modeling was performed to obtain SNPs CYP2C9 and molecular docking was performed to predict the effect of SNPs CYP2C9 on the metabolic activity of S-warfarin. Results: The results showed that wild-type CYP2C9 had the strongest binding affinity (∆G: -9.76 kcal/mol), indicating that wild-type CYP2C9 had the best metabolic activity compared to SNPs CYP2C9. There was a decrease in hydrogen bond formation in SNPs CYP2C9 and an increase in the distance between C7 S-warfarin and Fe-Heme in CYP2C9 SNPs when compared to wild-type CYP2C9 Conclusion: The decrease in binding affinity, decrease in hydrogen bond forma...
Aim:The study objectives were to investigate the association between selected CYP2C9 and VKORC1 sing...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
We report the first genome-wide association study (GWAS) whose sample size (1,053 Swedish subjects) ...
Objective: This study aimed to predict the effect of SNPs CYP2C9 s on the metabolic activity of S-wa...
<div><p>Cytochrome P450 2C9 (CYP2C9) is crucial in excretion of commonly prescribed drugs. However, ...
The aim of this study was to determine the association of bleeding as a complication of warfarin the...
Cytochrome P450 2C9 (CYP2C9) is crucial in excretion of commonly prescribed drugs. However, changes ...
Cytochrome P450 2C9 (CYP2C9) metabolizes many clinically important drugs including warfarin and dicl...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...
Warfarin is the most commonly used drug for chronic prevention of thromboembolic events, it also ran...
Background: Many genome-wide association studies focus on associating single loci with target phenot...
Objective: Genetic polymorphisms of CYP2C9 and VKORC1 play major role in pharmacokinetics and pharma...
Background: Warfarin is the most widely used oral anticoagulant for the prevention and treatment of ...
Objectives: Warfarin is a commonly prescribed anticoagulant drug used to prevent thromboses that may...
This work was supported by the Wellcome Trust. The work was also supported by the Swedish Science Co...
Aim:The study objectives were to investigate the association between selected CYP2C9 and VKORC1 sing...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
We report the first genome-wide association study (GWAS) whose sample size (1,053 Swedish subjects) ...
Objective: This study aimed to predict the effect of SNPs CYP2C9 s on the metabolic activity of S-wa...
<div><p>Cytochrome P450 2C9 (CYP2C9) is crucial in excretion of commonly prescribed drugs. However, ...
The aim of this study was to determine the association of bleeding as a complication of warfarin the...
Cytochrome P450 2C9 (CYP2C9) is crucial in excretion of commonly prescribed drugs. However, changes ...
Cytochrome P450 2C9 (CYP2C9) metabolizes many clinically important drugs including warfarin and dicl...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...
Warfarin is the most commonly used drug for chronic prevention of thromboembolic events, it also ran...
Background: Many genome-wide association studies focus on associating single loci with target phenot...
Objective: Genetic polymorphisms of CYP2C9 and VKORC1 play major role in pharmacokinetics and pharma...
Background: Warfarin is the most widely used oral anticoagulant for the prevention and treatment of ...
Objectives: Warfarin is a commonly prescribed anticoagulant drug used to prevent thromboses that may...
This work was supported by the Wellcome Trust. The work was also supported by the Swedish Science Co...
Aim:The study objectives were to investigate the association between selected CYP2C9 and VKORC1 sing...
What is known and Objectives: Testing for cytochrome P450-2C9 (CYP2C9) and vitamin K epoxide reduct...
We report the first genome-wide association study (GWAS) whose sample size (1,053 Swedish subjects) ...